Summary by Moomoo AI
As of November 30, 2024, Hansen Pharmaceuticals has filed its latest monthly statement of share capital movements. The report shows that the total authorized/registered share capital of the company remained at HK$200,000 with no change. The number of issued shares remained the same, with a total of 5,935,650,070 shares, with no additions or decreases.In addition, the Zero-Dividend Convertible Notes referred to in the report issued on January 22, 2021, will mature in 2026 totaling $5,378,000, with no change during the month. The conversion price of these bonds is HK$57.48 per share, which may result in the issuance of 725,384 new shares.Overall, Johnson Pharma's equity structure remained stable during the month with no significant changes.